Merge Labs is a research laboratory headquartered in the SF Bay Area that focuses on the intersection of biological and artificial intelligence. The company's core work involves developing fundamentally new brain-computer interface technologies designed to communicate with the brain at high bandwidth, crucially without the use of implants.
The company's technical approach spans several domains, including brain-computer interfaces, neurotechnology, artificial intelligence, ultrasound modalities, and molecular interfacing. This positions Merge Labs within the broader biotechnology, neurotechnology, and medical devices sectors.
Merge Labs has secured over $250 million in funding to support its research and development efforts.
